48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)

Detalles Bibliográficos
Autores principales: Arastéh, K, Ward, A, Plettenberg, A, Livrozet, JM, Cordes, C, Winston, A, Wang, E, Quinson, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113048/
http://dx.doi.org/10.1186/1758-2652-13-S4-P45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113048/
http://dx.doi.org/10.1186/1758-2652-13-S4-P45

Ejemplares similares